you were very prescient in your research and calls. one of the best mssg. bd. calls i ever saw. you have moved to stockwits? the discussion there i was not impressed with although the news feed is vastly better than yahoo.
please look up the definition of a short squeeze. the price moving 8% in their favor as the CEO sold shares, is not really a short squeeze. in fact, it is the opposite of a short squeeze. and as i have repeatedly said, there has not been one, and likely wont be one. one might argue even that the stock has been artificially supported by the buyback and covering, saving us from a price significantly lower.
hlf did not move. there was no short squeeze in hlf. in fact, i think the SS is a chimera, a unicorn. and mygn is not like hlf at all, except to say that the short position in hlf is very, very well controlled at this point, as it is in mygn. with the ceo even assisting the short argument.
i still do not know the benefit of prolaris. although i am told there is one. and before you go OMG how do you not know that? apparently, not many others know it. apparently there has been a significant delay in the reimbursement ruling as well. june it was expected. now maybe august? or the fall?
sorry, i have not been too impressed at how they are building business momentum. neither has Zacks, neither the billion dollars in short bets.
i was hoping that they would have announced new management and the stock would have rebounded. new 52 lows in july are a disaster for investors. weird that the artificial preservatives being added in michigan does make millions for the company. so counter-intuitive. i know that most people feel better when the sodium benzoate is local and added by a generic bottler.
great job by the analysts. upgrading when the stock is high and downgrading when the stock was low. so i would say meaningless. when the ceo is selling, you have a pretty good indication of where they think the business is going. although i do admire the ethics here. have the company buy shares to prop up the price, then have executives sell shares at the inflated price. replace the shares with dilution at the expense of the shareholder at 25% or market value. i think its like embezzling, but with lawyers and SEC filings. now someone please tell us at another conference how the sellers are misplaced in their judgment. if they dont crush earnings, it will be under $30 in a few weeks. maybe a buying opportunity, but i think the ceo and others selling, is a big, red flag which makes Zacks warnings look prescient.
by the way, funded from improving profitability? did i miss something? there aint no profitability. maybe funded by shareholder dilution and long term debt would be a better plan? look, advertising is smart when it is done wisely. i dont see this ad as wisely done. REEDS GINGER BREW! we brew it using all natural ingredients, we are craft soda! are you are drinking ginger ale made with corn syrup? did you get tricked into ordering a ginger corn soda by some giant corporation? dude. try a real ginger brew.
i think the ad is a bit above the level of a local auto mall production. certainly made for cable quality. its ok as an ad. a lot of verbiage and not a lot of education as to why it is different than commercial ginger ales. i think that is giant missed opportunity. however, it really features CHRIS REED!! and that is important because its CHRIS REEDS company. so the important thing was accomplished. i can not comment on anything about spend or selected channels. you see the huge problem with virgils and reeds disparate lines. no mention of virgils; another missed opportunity and not how i would build the brand. but whatever. CHRIS REED everybody! lets open on grey pony tail and pull away and ...... cut.
i think if there was a marketing plan in place, advertising is a good strategy. i do not believe there is a marketing plan in place. KOMBUCHA!!! SQUIRREL! GINGER!! it is all over the map. they need a great marketing mind to build the brands. they need to distinguish what is different from current product. that they utterly failed to do. and i dont get why they missed that point.
in the absence of a business plan or creative leadership, it is nice to ponder how a 15,000 shares will impact company valuation. this is why the stock price hasn't moved in a decade. what if they change to LED lights in mens' room? that will save some money too.
i will not suggest this stock as investment that can be held for long term, until there is a dramatic change in the business where growth is a priority and shareholders are considered important. up til now, this has largely been a company run by the executives for the executives.
Myriad Genetics, Inc. (MYGN) went down 3% yesterday after the company’s President and CEO Peter D. Meldrum sold 24,000 of his shares for $39.50 a piece, on the same day that he exercised a non-qualifying stock option to buy the same number of shares for $9.04 apiece.
Myriad share price decreased by $1.30 after the $948,000 deal was executed.
Chief Scientific Officer Jerry Lanchbury executed a stock sale of 20,000 shares at an average price of $39.85. This sale landed yet another blow to investors’ confidence in the company.
Myriad Genetics is a leading molecular diagnostic company, and has a market capitalization of $2.93 billion. Its fundamentals have been very strong over the years; it has consistently beat the Street’s sales and earnings estimates for the past eight quarters.
The company reported earnings per share (EPS) of $0.48 for the first quarter of fiscal 2014 (1QFY14), and beat Reuters’s EPS estimate by three cents. It is expected that FY14 revenues will increase 26.6% to $776.3 million. EPS is projected to rise 35.3% to $2.40.
The company has laid out a strategy to expand in the hereditary-cancer treatment market, and is launching new life-saving products. The majority of growth has come from the drug market, particularly in the oncology and women’s health businesses.
Of 21 analysts covering the stock, seven have rated it a Buy, and 12 a Hold. Currently, the stock is trading at $39.11, and according to analysts the target price is $40.17, reflecting an upside of 2.71%.
SO, my concern that the management was complacent is confirmed. i did not know medlrum was dumping stock and printing himself new shares at my expense. thanks peter for going to work today. i so appreciate it. and this is why its taken more than 13 years for the stock to not reach new highs. management doesnt care much since they can print their own cash. maybe it is part of the new corporatist fascism which rules the country. maybe he just doesnt care much about shareholders
i do not like the way drug companies have taken advertising direct to consumer. the fda has made it a comical farce. advertise to doctors in a responsible way. not consumers who the drug company is trying to fool and pressure. however, mygn shoudl absolutely be advertising as the gold standard in breast cancer testing. patients will get fooled into less effective and cheaper tests by their doctors and insurers. fully appropriate. yet they dont. we removed your breasts and saved ourselves $300 using labcorp's pretty good test. shhh. with a more aggressive management looking to expand services, they would have been a household name. they loved ms. jolie. loooooved. so how do you squander that opportunity to run the table? they are doing a good job, but they can improve in so many areas that they have neglected for 15 years. i hope that they have regained some self-confidence at this point.
this could be a global 50-100 billion dollar company that does great things for humanity. however, they seem to be aiming low and lack aggressiveness. a new ceo might be in order before a drug company buys them for cashflow and puts them on a back burner. they need to stop messing around and decide to set the global bar for genetic testing in an effective, ethical way.
dumbest thing i have ever seen. where is carol?
The fundamentals alone will dictate a price of $300 within 5 yrs. or so; the shorts will make it happen much sooner.
yes, the earnings will go up a factor of 1 every six months. sure.
thoughtful answer manuel. of course the company has people who like the product and buy it. however, they are not on trend and their current attempts to follow the natural trend will fail. the demo for 35 yo men drinking soda is collapsing. and the gourmet section of the market is not their sector. they suggest they are premium. relative to coke or pepsi they are premium. but they are a premium soda at the walmart level. walmart is notorious for pressuring margins of vendors. sometimes to the point of breaking the vendor. at this stage that is likely where walmart has jones. and it is not likely that they can make money on walmart sales. it is a bad scene.
the new flavor introduction is an example of how lost the company is. it is like jc penney buying new manikins and thinking they did something vital. so too the michigan nonsense. they are playing small ball and hoping the ongoing losses minimize to get to a point where they are almost breaking even. it is good for employees. for investors, it will be enshrine the disaster.
i am glad you like what she is doing. what products do you order? i assume you are ordering from the website because there is no place to purchase near you. i have no doubt the web site is user friendly to order from. it is 2014 after all. empty fields and links that have empty pages, details of descriptions missing, is what i was pointing out. CFOs tend not to leave a public company in the middle of a great boon in business. i think she saw no further future and took a different opportunity. the market seems to agree. but please tell me what products they make that you are willing to pay $2 a soda for and wait for delivery? why are you a fan?
you miss the point. they dont have anything of impact to announce so they are issuing silly and meaningless PRs. this is the busy season and the stock dropped on concern over growth. the lack of news confirms the concerns.
make no mistake, if this earnings cc is the same barrel of excuses (carrie quit for a reason), then the stock is going back to 20 cents this year. there appears to be little reason at this point for the doors to be open. unless soda for children becomes a growth category again. the naturals line is a joke and should be entirely discounted, since they can not even be bothered to say what is in it. the most basic concepts of selling a product? 25 people and the website looks like the have a 12 year old intern designer and webmaster.
what a sad, sad mess. but hey, you see all the positive press and fan enthusiasm on this board and from bloggers. a real viral success story. (sarcasm - there is no buzz, no viral anything, just sad reviews from years ago on youtube, google, etc.. )
ukraine is a big future market for them. like canada is now (sarcasm). nice old article on jones in the seattle paper on how they screwed up. nothing has changed.
you utterly miss the point. why is reed releasing a PR to state that a distributor in western north carolina that carries their products is expanding their distribution in the area? it is so trivial and inconsequential, yet they saw the need to release some news, without having anything to announce of even mild impact? in a company with a supposed 20% yoy and 100% kombucha yoy, the last thing i would expect is such news. since the concern among investors has been slowing gorwth, such a pr would indicate that little is happening of note in the business in their busiest season. my comments didnt cause a 50% crash in the stock, chris reed's comments did. the earnings announcements did.
like todays, i think it is a sign of trouble. it smells of desperation. you announced an expansion in a part of one state where distribution already underway with an existing distributor? what did that cost - a grand to release? maybe everyone is just chilling for the summer, waiting for the sweepstakes winner to be announced. btw, the expansion of what? to where? to what effect? why? just so amateur. is there a professional responsible for this nonsense?
stunning salaries for the executives of this company that can not make a profit. $125k a location is the valuation now? each store is worth the same as a nice bmw. yet, the ceo makes 800K? lol. postpone bankruptcy as long as possible to milk the cow.